Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: Brazil Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20171
20192
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Active, not recruiting1
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.1
Daiichi Sankyo1
Hospital Israelita Albert Einstein1
Hospital Municipal São José1
Hospital de Clinicas de Porto Alegre1
Novartis Pharmaceuticals1
OncoVerity, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute8
Leukemia2
Myelodysplastic Syndromes2
Myeloproliferative Disorders2
Anemia, Refractory, with Excess of Blasts1
Leukemia, Myelomonocytic, Chronic1
Polycythemia Vera1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Primary Myelofibrosis1
Thrombocythemia, Essential1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.